AQST

Aquestive Therapeutics, Inc. Common Stock

3.17

USD

AQST Earnings Reports

Positive Surprise Ratio

AQST beat 15 of 30 last estimates.

50%

Next Report

Date of Next Report

Mar 03, 2026

Estimate for Q4 25 (Revenue/ EPS)

$13.55M

-$0.13

Implied change from Q3 25 (Revenue/ EPS)

+5.80%

-7.14%

Implied change from Q4 24 (Revenue/ EPS)

+25.91%

-31.58%

Aquestive Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 05, 2025, AQST reported earnings of -0.14 USD per share (EPS) for Q3 25, missing the estimate of -0.13 USD, resulting in a -3.55% surprise. Revenue reached 12.81 million, compared to an expected 13.20 million, with a -3.00% difference. The market reacted with a +2.17% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 11 analysts forecast an EPS of -0.13 USD, with revenue projected to reach 13.55 million USD, implying an decrease of -7.14% EPS, and increase of 5.80% in Revenue from the last quarter.

FAQ

What were Aquestive Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Aquestive Therapeutics, Inc. Common Stock reported EPS of -$0.14, missing estimates by -3.55%, and revenue of $12.81M, -3% below expectations.

How did the market react to Aquestive Therapeutics, Inc. Common Stock's Q3 2025 earnings?

The stock price moved up 2.17%, changed from $6.00 before the earnings release to $6.13 the day after.

When is Aquestive Therapeutics, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 03, 2026.

What are the forecasts for Aquestive Therapeutics, Inc. Common Stock's next earnings report?

Based on 11 analysts, Aquestive Therapeutics, Inc. Common Stock is expected to report EPS of -$0.13 and revenue of $13.55M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.